Gastric cancer (GC) is a severe malignancy, accounting for the third most common cancer
death worldwide. Despite the development of chemo-radiation therapy, there has not been …

Gastric cancer (GC) is an aggressive malignancy that is the third leading cause of cancer
mortality worldwide. Localized GC can be cured with surgery, but most patients present with …

Cancer genome sequencing methods have now become essential for diagnostic purposes,
for devising treatment strategies, and for monitoring disease regression and progression …

Gastric cancer (GC) is one of the leading causes of cancer-related death. The combination
of new molecular classifications with clinicopathological data could contribute to the …

Gastric cancer (GC) is a heterogeneous disease. This heterogeneity applies not only to
morphological and phenotypic features but also to geographical variations in incidence and …

Background Fluoropyrimidine plus platinum chemotherapy remains the standard first line
treatment for gastric cancer (GC). Guidelines exist for the clinical interpretation of four DPYD …

Gastric cancer (GC) is a complex and heterogeneous disease. In recent decades, The
Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) defined GC …

Latin-America (LATAM) is the second region in gastric cancer incidence; gastric
adenocarcinoma (GA) represents 95% of all cases. We provide a mutational landscape of …

Gastric cancer (GC) is a common malignancy with the highest mortality rate among diseases
of the digestive system, worldwide. The present study of GC alterations is crucial to the …

Planificación sanitaria a partir de los datos ómicos: ¿es posible esta idea para Chile?
SciELO - Scientific Electronic Library Online vol.149 número11 Impacto social de la …